Mandatory Prescriber Education for NY State Licensed Health Professionals


RELEASE DATE:  May 25, 2017                                        

EXPIRATION DATE: May 25, 2018

ESTIMATED TIME TO COMPLETE ACTIVITY: 3 HOURS


Authors

Daniel Cartledge, MD, FAAPM, FAAPMR, Interventional Pain Management Specialist, National Pain Institute, Delray Beach, FL
Regina Napolitano, RN, MA, Infection Control & Patient Safety Education Development Specialist, ProCEO Inc, Delray Beach, FL
Claude Baconcini, CRNA, Chief CRNA, ProHealth Ambulatory Surgery Center, New Hyde Park, NY


Target Audience

New York State Licensed physicians, physician assistants, and nurse practitioners with DEA registration to prescribe controlled substances.


Curriculum

This activity has been developed to meet the requirements of the New York State mandate for training in this area. The curriculum is as follows:

ELEMENT 1: Federal and NY State Regulations Affecting Prescribers of Controlled Substances
ELEMENT 2: Pain Management - Patient Assessment
ELEMENT 3: Management of Acute Pain
ELEMENT 4: Appropriate Prescribing of Opioids and Mangement of Chronic Pain
ELEMENT 5: Screening Patients for Addiction and Appropriate Responses
ELEMENT 6: Palliative Medicine and End of Life Care


Sponsorship

Jointly provided by Postgraduate Institute for Medicine and ProCEO Inc.

PIM logo ProCEO logo


Educational Objectives

Upon completion of this educational activity, the participant will be able to:

  1. Adhere to the requirements defined in Federal and NY State laws for prescribing controlled substances and for electronic prescribing.

  2. State the benefits of consulting the State Prescription Monitoring registry prior to issuing an opioid prescription.

  3. Select a pain assessment tool appropriate to their patient population.

  4. Formulate a plan for assessing and mitigating risks for patients who require opioid treatment.

  5. Employ a multimodal approach to the treatment of acute pain.

  6. List several non-opioid adjuvants for treatment of acute postoperative pain.

  7. Identify patients who have higher risk of complications from long term opioid therapy.

  8. Describe circumstances when it is appropriate to discontinue long term opioid therapy for a patient with chronic pain.

  9. Choose appropriate pain interventions for patients with opioid use disorder.

  10. Assist patients with aberrant drug behavior in receiving appropriate intervention.

  11. Outline effective pharmaceutical and nonpharmaceutical approaches in palliative care pain management.

  12. Discuss the management of symptoms that are common to patients at the end of life.


Instructions For Completing This Activity and Obtaining Credit

You must register for the course by clicking the buton titled REGISTER FOR COURSE. As you read through the material on the course pages, you will be occasionally prompted to answer exam questions. There is a total of 42 multiple choice questions in this course. You must achieve a grade > 80% (34 correct answers) to receive a certificate and obtain credit.

When you have answered the last exam question, the Course Results page will display. This page will contain your final grade and allow you to immediately print your certificate if you have scored a passing grade. Your certificate will also be available on your Student Control Panel where you may print it at any time.

Course work does not need to be completed in one online session. You can log off at any point and return to your place in the course at your convenience. Participants are given two opportunities to pass the course.

The Course Reference Page is available (from the Control Panel) upon successful completion of the course. This reference page contains links to all of the reference documents mentioned in this activity as well as access to a document with the full course text. There are also links to information from nationally recognized sources that provide information that expands upon topics covered in this course.


Registration Fee

The registration fee for this course is $35.00. A discounted registration fee is available to qualified registrants from institutions that have made an arrangement with ProCEO for special pricing. Registrants who are eligible for a discount must enter the Discount code in the appropriate box during the registration process in order to receive a discounted rate.

Your registration fee includes two opportunities to pass the examination.

If you have any questions or concerns about this course, you may contact a Customer Service representative at 888-345-6788, or e-mail us at ceo.contact7@proceo.com.


Hardware / Software Requirements

Participants will need a computer or any device with an internet connection, a W3C standards compliant browser such as Internet Explorer 7 or higher, Firefox 3.5 or higher, Chrome 9 or higher, Safari 4 or higher, Opera 10 or higher; and Adobe Acrobat Reader for reviewing some of the reference material that can be accessed after completion of the course.


Accreditation and Disclosures

Physician Continuing Medical Education

This activity has been planned and implemented in accordance with the accreditation requirements and policies of the Accreditation Council for Continuing Medical Education (ACCME) through the joint providership of Postgraduate Institute for Medicine and ProCEO Inc. The Postgraduate Institute for Medicine is accredited by the ACCME to provide continuing medical education for physicians.

The Postgraduate Institute for Medicine designates this enduring material for a maximum of 3.0 AMA PRA Category 1 Credit(s). Physicians should claim only the credit commensurate with the extent of their participation in the activity.

Disclosure of Conflicts of Interest

Postgraduate Institute for Medicine (PIM) requires instructors, planners, managers and other individuals who are in a position to control the content of this activity to disclose any real or apparent conflict of interest (COI) they may have as related to the content of this activity. All identified COI are thoroughly vetted and resolved according to PIM policy.  PIM is committed to providing its learners with high quality CME activities and related materials that promote improvements or quality in healthcare and not a specific proprietary business interest of a commercial interest.

The authors have nothing to disclose.

The PIM planners and managers, Trace Hutchison, PharmD, Samantha Mattiucci, PharmD, CHCP, Judi Smelker-Mitchek, MBA, MSN, RN, and Jan Schultz, MSN, RN, CHCP have nothing to disclose.

Disclosure of Unlabeled Use

This educational activity may contain discussion of published and/or investigational uses of agents that are not indicated by the FDA. The planners of this activity do not recommend the use of any agent outside of the labeled indications. 

The opinions expressed in the educational activity are those of the faculty and do not necessarily represent the views of the planners.  Please refer to the official prescribing information for each product for discussion of approved indications, contraindications, and warnings.

Disclaimer

Participants have an implied responsibility to use the newly acquired information to enhance patient outcomes and their own professional development. The information presented in this activity is not meant to serve as a guideline for patient management. Any procedures, medications, or other courses of diagnosis or treatment discussed or suggested in this activity should not be used by clinicians without evaluation of their patient's conditions and possible contraindications and/or dangers in use, review of any applicable manufacturer's product information, and comparison with recommendations of other authorities.


Contact Information

To contact the Postgraduate Institute for Medicine, please CLICK HERE.

If you have questions about this training or require assistance with registration or with completing this course, please contact ProCEO Customer Service at 888-345-6788 or send e-mail to ceo.contact7@proceo.com.

For information on how to notify the State of New York that you have completed the required training, CLICK HERE.